Almirall announces Ron Menezes as new President & General Manager at Aqua Pharmaceuticals

Almirall S.A. announced the appointment of Ron Menezes as the new President & General Manager of Aqua Pharmaceuticals. He will be joining Aqua on September and will bring with him broad experience in the field of Dermatology in the US, the largest and most important market in the world.

According to Eduardo Sanchiz, Almirall’s CEO, “we are very pleased to announce the appointment of Ron Menezes as the new President & GM of Aqua Pharmaceuticals reporting to Alfonso Ugarte, Executive Vice-president of Commercial Strategy. Ron’s incorporation and the experience he brings in dermatology represent a clear and undeniable opportunity to further strengthen this organization. Almirall continues to consider Aqua as a very important platform in the US market to support existing and new products”.

Most recently Ron was at Depomed Pharmaceuticals serving as Vice President of Sales and Sales Operations, Pain and CNS Portfolio. Prior to that, Ron had a very successful career at Allergan where he started as National Sales Director of Medical Dermatology. Later, and after showing outstanding results, he was promoted to Vice President Sales and Marketing, Medical Dermatology and, finally, and he was given additional responsibilities leading both the Medical Dermatology and SkinMedica team. Before Allergan, Ron held leadership positions at Abbott, Astellas and Pfizer.

Ron has a B.S. International Business from Brigham Young University and a Health Care Management graduate certificate from the University of Utah.

He will be replacing Ted White, who has been President and General Manager of the company since January 2016. Almirall would like to sincerely thank Ted White, for his efforts and contribution during the last 7 years that he has worked at Aqua Pharmaceuticals. His contribution has been key to achieve the success that Aqua has had in the past.

N.B. – The text does not bind the staff of LMFInternational. Only the companies, organizations and associations which sign the press release and which are clearly indicated in the title of the text, are responsible for its information and contents.